The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chu, N. R.
Right arrow Articles by Watts, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chu, N. R.
Right arrow Articles by Watts, T. H.

The Journal of Immunology, Vol 158, Issue 7 3081-3089, Copyright © 1997 by American Association of Immunologists

ARTICLES

Role of IL-12 and 4-1BB ligand in cytokine production by CD28+ and CD28- T cells

NR Chu, MA DeBenedette, BJ Stiernholm, BH Barber and TH Watts
Department of Immunology, University of Toronto, Ontario, Canada.

The costimulatory receptor CD28 is important in the development of both Th1 and Th2 responses. To further assess the requirement for CD28 in the development of Th1 and Th2 responses, we analyzed the ability of T cells from wild-type or CD28- mice to secrete cytokines in MLRs with B lymphomas. We find that in the absence of added IL-12, B lymphomas expressing the alternate costimulatory ligand 4-1BBL can support the production of IL-2 and IL-4 but little detectable IFN-gamma by allogeneic CD28+ and CD28- T cells. IL-4 production by CD28+ or CD28- T cells responding to B7(low) B lymphomas was abrogated by blocking 4-1BB ligand-4-1BB interaction. When APC express high levels of B7 family molecules as well as 4-1BBL, soluble 4-1BB inhibits IL-4 production by CD28- but not by CD28+ cells. Addition of IL-12 to the CD28- MLRs results in increased production of IFN-gamma and decreased amounts of IL-2 and IL-4. Thus, both Th1 and Th2 responses can develop in the complete absence of a signal through the CD28 molecule. CD28+ and CD28- T cells differed, however, with respect to the effect of IL-12 on IL-4 production. IL-12 severely curtailed the amount of IL-4 produced in the CD28- T cell cultures but had a less profound effect on the level of IL- 4 produced in the CD28+ cultures, suggesting that a strong signal through the CD28 molecule prevents down-regulation of IL-4 production by IL-12.


This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
S. M. Shin, Y. H. Kim, B. K. Choi, P. M. Kwon, H.-W. Lee, and B. S. Kwon
4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation
J. Leukoc. Biol., June 1, 2007; 81(6): 1455 - 1465.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. Zhang, R. E. Sadun, R. S. Arias, M. L. Flanagan, S. M. Sachsman, Y.-C. Nien, L. A. Khawli, P. Hu, and A. L. Epstein
Targeted and Untargeted CD137L Fusion Proteins for the Immunotherapy of Experimental Solid Tumors
Clin. Cancer Res., May 1, 2007; 13(9): 2758 - 2767.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. S. Vinay, J. D. Kim, and B. S. Kwon
Amelioration of Mercury-Induced Autoimmunity by 4-1BB
J. Immunol., October 15, 2006; 177(8): 5708 - 5717.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
M. Stasiolek, A. Bayas, N. Kruse, A. Wieczarkowiecz, K. V. Toyka, R. Gold, and K. Selmaj
Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis
Brain, May 1, 2006; 129(5): 1293 - 1305.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. Nishimoto, S.-W. Lee, H. Hong, K. G. Potter, M. Maeda-Yamamoto, T. Kinoshita, Y. Kawakami, R. S. Mittler, B. S. Kwon, C. F. Ware, et al.
Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor
Blood, December 15, 2005; 106(13): 4241 - 4248.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. Shao, Y. Fu, T. Liao, Y. Peng, L. Chen, H. J. Kaplan, and D. Sun
Anti-CD137 mAb Treatment Inhibits Experimental Autoimmune Uveitis by Limiting Expansion and Increasing Apoptotic Death of Uveitogenic T Cells
Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 596 - 603.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Saito, N. Ohara, H. Hotokezaka, S. Fukumoto, K. Yuasa, M. Naito, T. Fujiwara, and K. Nakayama
Infection-induced Up-regulation of the Costimulatory Molecule 4-1BB in Osteoblastic Cells and Its Inhibitory Effect on M-CSF/RANKL-induced in Vitro Osteoclastogenesis
J. Biol. Chem., April 2, 2004; 279(14): 13555 - 13563.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Bukczynski, T. Wen, K. Ellefsen, J. Gauldie, and T. H. Watts
Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses
PNAS, February 3, 2004; 101(5): 1291 - 1296.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. J. Shedlock, J. K. Whitmire, J. Tan, A. S. MacDonald, R. Ahmed, and H. Shen
Role of CD4 T Cell Help and Costimulation in CD8 T Cell Responses During Listeria monocytogenes Infection
J. Immunol., February 15, 2003; 170(4): 2053 - 2063.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
Z.-Q. Wu, A. Q. Khan, Y. Shen, K. M. Wolcott, W. Dawicki, T. H. Watts, R. S. Mittler, and C. M. Snapper
4-1BB (CD137) Differentially Regulates Murine In Vivo Protein- and Polysaccharide-Specific Immunoglobulin Isotype Responses to Streptococcus pneumoniae
Infect. Immun., January 1, 2003; 71(1): 196 - 204.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. L. Cannons, E. M. Bertram, and T. H. Watts
Cutting Edge: Profound Defect in T Cell Responses in TNF Receptor-Associated Factor 2 Dominant Negative Mice
J. Immunol., September 15, 2002; 169(6): 2828 - 2831.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Wen, J. Bukczynski, and T. H. Watts
4-1BB Ligand-Mediated Costimulation of Human T Cells Induces CD4 and CD8 T Cell Expansion, Cytokine Production, and the Development of Cytolytic Effector Function
J. Immunol., May 15, 2002; 168(10): 4897 - 4906.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Diehl, G. J. D. van Mierlo, A. T. den Boer, E. van der Voort, M. Fransen, L. van Bostelen, P. Krimpenfort, C. J. M. Melief, R. Mittler, R. E. M. Toes, et al.
In Vivo Triggering Through 4-1BB Enables Th-Independent Priming of CTL in the Presence of an Intact CD28 Costimulatory Pathway
J. Immunol., April 15, 2002; 168(8): 3755 - 3762.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. M. Bertram, P. Lau, and T. H. Watts
Temporal Segregation of 4-1BB Versus CD28-Mediated Costimulation: 4-1BB Ligand Influences T Cell Numbers Late in the Primary Response and Regulates the Size of the T Cell Memory Response Following Influenza Infection
J. Immunol., April 15, 2002; 168(8): 3777 - 3785.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. Yamada, A. D. Salama, and M. H. Sayegh
The Role of Novel T Cell Costimulatory Pathways in Autoimmunity and Transplantation
J. Am. Soc. Nephrol., February 1, 2002; 13(2): 559 - 575.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Sun, X. Lin, H. M. Chen, Q. Wu, S. K. Subudhi, L. Chen, and Y.-X. Fu
Administration of Agonistic Anti-4-1BB Monoclonal Antibody Leads to the Amelioration of Experimental Autoimmune Encephalomyelitis
J. Immunol., February 1, 2002; 168(3): 1457 - 1465.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Nozawa, J. Ohata, J. Sakurai, H. Hashimoto, H. Miyajima, H. Yagita, K. Okumura, and M. Azuma
Preferential Blockade of CD8+ T Cell Responses by Administration of Anti-CD137 Ligand Monoclonal Antibody Results in Differential Effect on Development of Murine Acute and Chronic Graft-Versus-Host Diseases
J. Immunol., November 1, 2001; 167(9): 4981 - 4986.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. R. Salih, H. M. Schmetzer, C. Burke, G. C. Starling, R. Dunn, R. Pelka-Fleischer, V. Nuessler, and P. A. Kiener
Soluble CD137 (4-1BB) Ligand Is Released Following Leukocyte Activation and Is Found in Sera of Patients with Hematological Malignancies
J. Immunol., October 1, 2001; 167(7): 4059 - 4066.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. L. Cannons, P. Lau, B. Ghumman, M. A. DeBenedette, H. Yagita, K. Okumura, and T. H. Watts
4-1BB Ligand Induces Cell Division, Sustains Survival, and Enhances Effector Function of CD4 and CD8 T Cells with Similar Efficacy
J. Immunol., August 1, 2001; 167(3): 1313 - 1324.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. R. Blazar, B. S. Kwon, A. Panoskaltsis-Mortari, K. B. Kwak, J. J. Peschon, and P. A. Taylor
Ligation of 4-1BB (CDw137) Regulates Graft-Versus-Host Disease, Graft-Versus-Leukemia, and Graft Rejection in Allogeneic Bone Marrow Transplant Recipients
J. Immunol., March 1, 2001; 166(5): 3174 - 3183.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
A. P. Makrigiannis, B. L. Musgrave, S. M. M. Haeryfar, and D. W. Hoskin
Interleukin-12 can replace CD28-dependent T-cell costimulation during nonspecific cytotoxic T lymphocyte induction by anti-CD3 antibody
J. Leukoc. Biol., January 1, 2001; 69(1): 113 - 122.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
J. L. Cannons, Y. Choi, and T. H. Watts
Role of TNF Receptor-Associated Factor 2 and p38 Mitogen-Activated Protein Kinase Activation During 4-1BB-Dependent Immune Response
J. Immunol., December 1, 2000; 165(11): 6193 - 6204.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. R. Salih, S. G. Kosowski, V. F. Haluska, G. C. Starling, D. T. Loo, F. Lee, A. A. Aruffo, P. A. Trail, and P. A. Kiener
Constitutive Expression of Functional 4-1BB (CD137) Ligand on Carcinoma Cells
J. Immunol., September 1, 2000; 165(5): 2903 - 2910.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
Y.-X. Zhao, G. Lajoie, H. Zhang, B. Chiu, U. Payne, and R. D. Inman
Tumor Necrosis Factor Receptor p55-Deficient Mice Respond to Acute Yersinia enterocolitica Infection with Less Apoptosis and More Effective Host Resistance
Infect. Immun., March 1, 2000; 68(3): 1243 - 1251.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. A. DeBenedette, T. Wen, M. F. Bachmann, P. S. Ohashi, B. H. Barber, K. L. Stocking, J. J. Peschon, and T. H. Watts
Analysis of 4-1BB Ligand (4-1BBL)-Deficient Mice and of Mice Lacking Both 4-1BBL and CD28 Reveals a Role for 4-1BBL in Skin Allograft Rejection and in the Cytotoxic T Cell Response to Influenza Virus
J. Immunol., November 1, 1999; 163(9): 4833 - 4841.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. L. Cannons, K. P. Hoeflich, J. R. Woodgett, and T. H. Watts
Role of the Stress Kinase Pathway in Signaling Via the T Cell Costimulatory Receptor 4-1BB
J. Immunol., September 15, 1999; 163(6): 2990 - 2998.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B.-a. Guinn, M. A. DeBenedette, T. H. Watts, and N. L. Berinstein
4-1BBL Cooperates with B7-1 and B7-2 in Converting a B Cell Lymphoma Cell Line into a Long-Lasting Antitumor Vaccine
J. Immunol., April 15, 1999; 162(8): 5003 - 5010.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
K. Saoulli, S. Y. Lee, J. L. Cannons, W. C. Yeh, A. Santana, M. D. Goldstein, N. Bangia, M. A. DeBenedette, T. W. Mak, Y. Choi, et al.
CD28-independent, TRAF2-dependent Costimulation of Resting T Cells by 4-1BB Ligand
J. Exp. Med., June 1, 1998; 187(11): 1849 - 1862.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.